JSS Sustainable Equity - Future Health C USD acc

Reference Data

ISIN LU2041625653
Valor Number 49473275
Bloomberg Global ID
Fund Name JSS Sustainable Equity - Future Health C USD acc
Fund Provider J. Safra Sarasin Investmentfonds AG Basel, Switzerland
Phone: +41 58 317 44 44
Web: www.jsafrasarasin.com
Fund Provider J. Safra Sarasin Investmentfonds AG
Representative in Switzerland J. Safra Sarasin Investmentfonds AG
Basel
Phone: +41 58 317 44 00
Distributor(s) Bank J. Safra Sarasin AG
Basel
Phone: +41 58 317 44 00
Asset Class Equities
EFC Category
Distribution Policy Accumulation
Home Country Luxembourg
Issuing Condition The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel)
Redemption Condition The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV)
Investment Strategy *** The investment objective of the fund is to achieve long-term capital growth. The Reference Currency of the Sub-Fund is the US Dollar (USD).
Peculiarities

Fund Prices

Current Price * 115.78 USD 21.05.2025
Previous Price * 117.67 USD 20.05.2025
52 Week High * 131.39 USD 30.08.2024
52 Week Low * 107.61 USD 08.04.2025
NAV * 115.78 USD 21.05.2025
Issue Price *
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 138,301,375
Unit/Share Assets *** 9,847,188
Trading Information SIX

Performance

YTD Performance +0.16% 31.12.2024
21.05.2025
YTD Performance (in CHF) -8.95% 31.12.2024
21.05.2025
1 month +1.59% 22.04.2025
21.05.2025
3 months -5.21% 21.02.2025
21.05.2025
6 months -1.40% 21.11.2024
21.05.2025
1 year -5.81% 21.05.2024
21.05.2025
2 years -7.61% 22.05.2023
21.05.2025
3 years -6.24% 23.05.2022
21.05.2025
5 years +1.16% 22.05.2020
21.05.2025

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

UnitedHealth Group Inc 9.27%
Eli Lilly and Co 6.74%
Sanofi SA 6.60%
Danaher Corp 6.30%
Gilead Sciences Inc 5.20%
Intuitive Surgical Inc 4.51%
Boston Scientific Corp 4.22%
Johnson & Johnson 4.17%
Novo Nordisk AS Class B 3.87%
argenx SE 3.71%
Last data update 31.03.2025

Cost / Risk

TER 1.39%
TER date 31.10.2024
Performance Fee ***
PTR
Max. Management Fee *** 1.50%
Ongoing Charges *** 1.38%
SRRI ***
SRRI date *** 30.04.2025

Breakdowns

Countries ***

Stock Sectors ***

Bond Sectors ***


* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)